A randomized, placebo controlled trial of prostacyclin (PGI 2) in peripheral arterial disease

Observational studies suggest that short term infusion of prostacyclin (PGI 2) may be of rapid and prolonged benefit in peripheral arterial disease. 10 patients with peripheral arterial disease received 72 hour intravenous infusions of PGI 2 and saline alone. The administration was randomized and si...

Ausführliche Beschreibung